Myasthenia Gravis and Pericarditis in a Patient with Thymoma: Myasthenia Gravis and Pericarditis

Ryan Fogg; Lillian Flashner; William Marte; Rabia Choudry; Anishee Undavia; Aparna Prabhu

doi:10.17161/rrnmf.v2i3.14790

Authors

Ryan W. Fogg BS Thomas Jefferson University
Lillian C. Flashner BS Sidney Kimmel Medical College at Thomas Jefferson University
William J. Marte MD Einstein Medical Center
Rabia B. Choudry MD
Anishee S. Undavia MD Einstein Medical Center
Aparna M. Prabhu MD Einstein Medical Center

DOI:

https://doi.org/10.17161/rrnmf.v2i3.14790

Keywords:

myasthenia gravis, pericarditis, myocarditis, cardiac involvement

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Guglin, Maya, et al. “Cardiac Disease in Myasthenia Gravis: A Literature Review.” Journal of Clinical Neuromuscular Disease, vol. 4, no. 4, 2003, pp. 199–203., doi:10.1097/00131402-200306000-00006

Vats, Hemender S., et al. “Pericarditis in Myasthenia Gravis.” Cardiology in Review, vol. 12, no. 3, 2004, pp. 134–137., doi:10.1097/01.crd.0000117762.62596.8d.

Priemer, David S, et al. “Giant Cell Polymyositis and Myocarditis in a Patient With Thymoma and Myasthenia Gravis: A Postviral Autoimmune Process?” Journal of Neuropathology & Experimental Neurology, vol. 77, no. 8, 2018, pp. 661–664., doi:10.1093/jnen/nly041.

Finsterer J, Stollberger C. “Stress from Myasthenic Crisis Triggers Takotsubo (broken heart) Syndrome.” Int J Cardiol 2016; 203: 616-617.

Hofstad H, Ohm OJ, Mork SJ, et al. “Heart disease in myasthenia gravis." Acta Neurol Scand. 1984; 70:176-184.

Romi F, Skeie G, Gilhus N, Aarli J. “Striational Antibodies in Myasthenia Gravis: reactivity and possible clinical significance.” Arch Neurol 2005;62(3): 442-446.

Shivamurthy, Poojita, and Matthew W. Parker. “Cardiac Manifestations of Myasthenia Gravis: A Systematic Review.” IJC Metabolic & Endocrine, vol. 5, 2014, pp. 3–6., doi:10.1016/j.ijcme.2014.08.003.

Suzuki, Shigeaki, et al. “Three Types of Striational Antibodies in Myasthenia Gravis.” Autoimmune Diseases, vol. 2011, 2011, pp. 1–7., doi:10.4061/2011/740583.

Glennon, P. E., et al. “Fatal Giant Cell Myocarditis after Resection of Thymoma.” Heart, vol. 75, no. 5, 1996, pp. 531–532., doi:10.1136/hrt.75.5.531.

Suzuki, Shigeaki, et al. “Nivolumab-Related Myasthenia Gravis with Myositis and Myocarditis in Japan.” Neurology, vol. 89, no. 11, 2017, pp. 1127–1134., doi:10.1212/wnl.0000000000004359.

Rota, Eugenia, et al. “Concomitant Myasthenia Gravis, Myositis, Myocarditis and Polyneuropathy, Induced by Immune-Checkpoint Inhibitors: A Life–Threatening Continuum of Neuromuscular and Cardiac Toxicity.” ENeurologicalSci, vol. 14, 2019, pp. 4–5., doi:10.1016/j.ensci.2018.11.023.

So, Hayato, et al. “PD-1 Inhibitor-Associated Severe Myasthenia Gravis with Necrotizing Myopathy and Myocarditis.” Journal of the Neurological Sciences, vol. 399, 2019, pp. 97–100., doi:10.1016/j.jns.2019.02.023.

Yamamoto, Ana Maria, et al. “Anti-Titin Antibodies in Myasthenia Gravis.” Archives of Neurology, vol. 58, no. 6, 2001, p. 885., doi:10.1001/archneur.58.6.885.

Wanner, William R., et al. “Postoperative Pericarditis Following Thymectomy for Myasthenia Gravis.” Chest, vol. 83, no. 4, 1983, pp. 647–649., doi:10.1378/chest.83.4.647.

Hikosaka, Yu, et al. “Post-Irradiation Constrictive Pericarditis Following Thymoma Treatment: a Report of Two Cases.” General Thoracic and Cardiovascular Surgery, vol. 63, no. 7, 2013, pp. 413–415., doi:10.1007/s11748-013-0302-9.

Myasthenia Gravis and Pericarditis in a Patient with Thymoma